InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+20.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Brinkley Ruth Williams, Director. Director active across 1 company, notably Travere Therapeutics, Inc.. Cumulatively, 8 reports have been published. History available since 14 September 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
86 sharesCommon StockSEC:0001344381-26-000002:0
6,500 shares0Common StockSEC:0001415889-25-013504:0
2,964 sharesCommon StockSEC:0001415889-24-019069:0
6,500 shares0Common StockSEC:0001415889-24-012852:0
4,500 shares0Common StockSEC:0001209191-23-030963:0
3,000 shares0Common StockSEC:0001209191-22-028704:0
5,250 shares0Common StockSEC:0001209191-21-056459
5,250 shares0Common StockSEC:0001209191-21-056459:0
8 of 8 declarations
About Brinkley Ruth Williams
Ruth Williams Brinkley is a Board Member at Travere Therapeutics, Inc. She plays a crucial role in overseeing the company's activities and making strategic decisions. With her experience in the industry, she contributes to implementing effective governance practices and achieving the company's objectives. Her commitment to innovation and corporate social responsibility is a valuable asset to the board.
